Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy.
Heather
H
Wood
D000818:Animals; D064113:CRISPR-Cas Systems / Q000235:genetics*; D016189:Dystrophin / Q000235:genetics*; D016678:Genome; D006801:Humans; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000235:genetics*; D009154:Mutation
D016189:Dystrophin